Triple-negative breast cancer (TNBC) is associated with poor prognosis and invalid therapeutical response to immunotherapy due to biological heterogeneity. There is an urgent need to screen for reliable indices. especially immunotherapy-associated biomarkers that can predict patient outcomes. Pyroptosis. https://www.animationbengal.com/?w=quick-buy-yale-bulldogs-law-school-discount-great-price